Correction to: Nature Communications https://doi.org/10.1038/s41467-019-09614-y, published online 09 April 2019.
The original version of this Article omitted the following from the Acknowledgements:
“G.B. acknowledges the support from the Cancer Prevention and Research Institute of Texas (RR140081 and RR170721).”
This has now been corrected in both the PDF and HTML versions of the Article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Pavel-Dinu, M., Wiebking, V., Dejene, B.T. et al. Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nat Commun 10, 2021 (2019). https://doi.org/10.1038/s41467-019-10080-9
Published:
DOI: https://doi.org/10.1038/s41467-019-10080-9
This article is cited by
-
Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome
Nature Communications (2020)
-
CRISPR-Cas9 Probing of Infectious Diseases and Genetic Disorders
The Indian Journal of Pediatrics (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
